Marijuana Stocks

Much like the U.S. legal status on marijuana, the verdict on marijuana stocks is still up in the air. While the bulls like to think that the marijuana industry is about to explode with their optimism over the pending decriminalization and legalization of marijuana, the bears view marijuana stocks as a very risky investment to the point that they may be scams. Marijuana Penny Stocks such as Cannabis Science Inc (CBIS) are risky due to fact that they are in a grey legal area. But as Canada’s nascent legal marijuana market blossoms, many pot stocks are worth adding to your portfolio.

Related to Marijuana Stocks:

Can You Call It a Comeback for Canopy Growth Stock?

CGC stock is rebounding to start 2020, but it's going to take more to convince investors this will be a name that leads cannabis this year.

Aurora Cannabis Stock Will Need Help for a 2020 Recovery

Aurora Cannabis has recently perked up, but plenty of challenges remain for ACB stock and upside could be limited over the course of 2020.

Hold Off on Buying Aurora Cannabis Stock for Now

OrganiGram gave the marijuana sector a much-needed boost. But Aurora stock will probably not be able to replicate its success anytime soon.

Is It Finally Time to Buy Aurora Cannabis Stock?

Aurora stock has tumbled to fresh lows, but analysts are divided on whether the drop is a buying opportunity. There are still plenty of risks ahead for Aurora, and there are better cannabis stocks out there.

How Long Can the Rally in Canopy Growth Stock Last?

Canopy Growth stock is up 21% since Monday, but the reality of Cannabis 2.0 is likely to take the momentum out of any recovery.

Here’s How Aphria Stock Could Double in 2020

Improving fundamentals and a favorable valuation lay the groundwork for a big rally by Aphria stock over the next 12 months.

CRON Stock Could Ride the Cannabis Resurgence into a Year-Long Rally

As a high-quality pick in a resurgent cannabis sector, CRON stock could be due for big returns in calendar 2020.

Why Canopy Growth Stock Holding $20 Might Go Up in Smoke

Canopy Growth’s prospects in 2020 look much like last year’s, but growing store count and Cannabis 2.0 might help Canopy Growth stock.

Hexo Stock May Bottom Here, but It Probably Won’t

Pot stocks will rebound in 2020, but HEXO stock may not join the party, as growth trends remain pressured by competition.

Here’s Why It’s Not Too Late to Buy Canopy Growth Stock

A major bottom is in, but there’s a better way to play Canopy Growth stock than buying shares today.

Should Investors Buy Aurora Stock in 2020?

ACB stock may continue to be punished until it becomes consistently profitable and improves cash flow

Stock Market Today: Jobs Disappoint, Aurora Cannabis Stock to $1? 

Six Flags cratered, the jobs report disappointed and Aurora Cannabis could have big downside. Here's what happened in the stock market today.

The Top 15 Stocks to Buy in 2020

These 15 excellent stocks to buy are well positioned to be big winners in 2020, thanks to strong fundamentals and favorable valuations.

Could the Pain Finally Be Over for Canopy Growth Stock?

After a dismal 2019, the owners of CGC stock are hoping for sunnier days ahead. Will Canopy Growth stock come through for them?

Two Key Questions for Canopy Growth Stock in 2020

2019 was an ugly year for Canopy Growth stock. CGC can rebound in 2020 if it can capitalize on key opportunities.

It Doesn’t Look as If the ACB Stock Turnaround Is Coming Any Time Soon

After struggling in 2019, investors are hoping for a fresh start for Aurora stock. Here are a few things you need to know about ACB stock.

Canopy Growth Stock Looks Ready to Gain From Big Catalysts in 2020

Canopy Growth stock investors are excited about a new CEO at the helm and new Cannabis 2.0 products on the way. CGC stock looks primed for 2020.

What Hexo Stock Needs Is Some Old-Fashioned Reaganomics

Last year was a year of reckoning for Hexo stock and the broader cannabis market. However, most of the pain may have resulted from unnecessary government inefficiencies.

Thursday’s Vital Data: Bristol-Myers Squibb, Cronos and Canopy Growth

Options trading was hot in Bristol-Myers Squibb, Cronos and Canopy Growth stock on Tuesday. Here’s what the data suggests moving forward.

Aurora Stock Will Have Another Rough Year

The shaky financials of Aurora stock make ACB stock one of the worst choices in the marijuana industry.